期刊
RADIOTHERAPY AND ONCOLOGY
卷 89, 期 1, 页码 13-18出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2008.05.021
关键词
Positron-emission tomography; Radiotherapy; Head and neck neoplasms
资金
- NCI NIH HHS [P01 CA059827, P01 CA059827-130008] Funding Source: Medline
Background and purpose: To assess whether the pretreatment FDG-PET-defined biologic target volume (PET-BTV) correlates with the anatomical sites of loco-regional failure (LRF) after RT for head and neck cancer (HNC). Materials and methods: We retrospectively identified 61 HNC patients treated definitively with either 3-D CRT or IMRT who had a pre-therapy PET/CT. The GTV and high-risk CTV1 definitions included composite data obtained from diagnostic CT, PET/CT, physical examination, and MRI when available. The median CTV1 dose was 70 Gy. 95% received chemotherapy. For patients with LRF, a recurrence volume (V-r) was identified and was mapped to the pretreatment planning CT and pretreatment PET scan. Results: At a median follow-up of 22 months, 15% (9/61) patients had LRF. For patients with a LRF, 100% (9/9) of failures were inside the GTV. One of nine [11% (95% Cl: 3-45%)] had V-r which mapped outside of the pretreatment PET-BTV, while 8/9 patients had Vr within the PET-BTV. Predictors of LRF in our series included GTV volume (p = 0.003), but not mean SUV (p = 0.13) or max SUV (p = 0.25). Conclusions: Following treatment in which the GTV was defined based on the composite of imaging and physical examination, the majority, but not all, LRF occurred within the PET-BTV. These results support an important, but not exclusive, role of FDG-PET in defining the GTV. (C) 2008 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 89 (2008) 13-18.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据